Woodcock Warns Research Apparatus Could Be Overwhelmed If Coronavirus Trials Don’t Use Master Protocols

 
• By Derrick Gingery

CDER Director Janet Woodcock says researchers need to embrace pragmatic trial designs and compare multiple treatments at the same time rather than employ separate development programs.

Coronavirus globe
CDER Director Janet Woodcock said master protocols could help assess repurposed drugs faster. • Source: Shutterstock

More from Clinical Trials

More from R&D